Synonyms: BTZ-10526043 | MMV676603
Compound class:
Synthetic organic
Comment: BTZ-043 is the lead from a novel class of benzothiazinone compounds with antimycobacterial activity [1], that is is under clinical evaluated as a treatment for tuberculosis (TB). It is an inhibitor of decaprenylphosphoryl-beta-D-ribose oxidase (DprE1), an essential mycobacterial cell wall biosynthesis enzyme [1-3].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-[(3S)-3-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one |
Synonyms ![]() |
BTZ-10526043 | MMV676603 |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
BTZ-043 |
Other databases | |
CAS Registry No. | 1161233-85-7 (source: Scifinder) |
ChEMBL Ligand | CHEMBL1822872 |
DrugBank Ligand | DB17737 |
GtoPdb PubChem SID | 485206155 |
PubChem CID | 42609849 |
Search Google for chemical match using the InChIKey | GTUIRORNXIOHQR-VIFPVBQESA-N |
Search Google for chemicals with the same backbone | GTUIRORNXIOHQR |
UniChem Compound Search for chemical match using the InChIKey | GTUIRORNXIOHQR-VIFPVBQESA-N |
UniChem Connectivity Search for chemical match using the InChIKey | GTUIRORNXIOHQR-VIFPVBQESA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
BTZ043 (links to external site)
Cat. No. HY-13579 |